Literature DB >> 22865903

Fracture risk assessment without race/ethnicity information.

Shinya Ishii1, Gail A Greendale, Jane A Cauley, Carolyn J Crandall, Mei-Hua Huang, Michelle E Danielson, Arun S Karlamangla.   

Abstract

CONTEXT: Dual-energy x-ray absorptiometry-derived bone mineral density (BMD) does not explain interracial differences in fracture risk; thus, BMD-based fracture risk assessment requires patient race/ethnicity information and ethnicity-specific BMD reference databases.
OBJECTIVE: The objective of the study was to investigate whether composite femoral neck strength indices, which integrate dual-energy x-ray absorptiometry-derived femoral neck size, femoral neck BMD, and body size, will allow fracture risk assessment without requiring race/ethnicity information.
DESIGN: This was a prospective cohort study. SETTING AND PARTICIPANTS: A total of 1940 community-dwelling women aged 42-53 yr from four race/ethnicity groups (968 Caucasian, 512 African-American, 239 Japanese, and 221 Chinese) were followed up for 9 yr. OUTCOME MEASUREMENTS: Self-reported, nondigital, noncraniofacial fractures were measured.
RESULTS: Two hundred and two women (10.4%) sustained fractures and 82 (4.3%) had minimum-trauma fractures. Each sd increment in any of the strength indices was associated with a 34-41% reduction in fracture hazard over 9 yr (each P<0.001). Race/ethnicity predicted fracture hazard independent of BMD (P=0.02) but did not predict fracture hazard independent of any of the composite indices (P=0.11-0.22). Addition of race/ethnicity did not improve risk discrimination ability of the strength indices, but did significantly improve the discrimination ability of BMD. The discrimination ability of BMD with race/ethnicity was not statistically different from that of any of the strength indices without race/ethnicity.
CONCLUSIONS: Composite strength indices of the femoral neck can predict fracture risk without race/ethnicity information as accurately as bone mineral density does in combination with race/ethnicity information and therefore would allow risk prediction in people of mixed race/ethnicity and in groups without a BMD reference database.

Entities:  

Mesh:

Year:  2012        PMID: 22865903      PMCID: PMC3462938          DOI: 10.1210/jc.2012-1997

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians.

Authors:  J Carpenter; J Bithell
Journal:  Stat Med       Date:  2000-05-15       Impact factor: 2.373

2.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

3.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies.

Authors:  J A Baecke; J Burema; J E Frijters
Journal:  Am J Clin Nutr       Date:  1982-11       Impact factor: 7.045

4.  Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.

Authors:  E S Siris; P D Miller; E Barrett-Connor; K G Faulkner; L E Wehren; T A Abbott; M L Berger; A C Santora; L M Sherwood
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

5.  Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group.

Authors:  D G Seeley; W S Browner; M C Nevitt; H K Genant; J C Scott; S R Cummings
Journal:  Ann Intern Med       Date:  1991-12-01       Impact factor: 25.391

6.  Bone loss and bone size after menopause.

Authors:  Henrik G Ahlborg; Olof Johnell; Charles H Turner; Gunnar Rannevik; Magnus K Karlsson
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

7.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

8.  Hip fracture risk assessment using composite indices of femoral neck strength: the Rancho Bernardo study.

Authors:  Arun S Karlamangla; Elizabeth Barrett-Connor; Jean Young; Gail A Greendale
Journal:  Osteoporos Int       Date:  2003-11-07       Impact factor: 4.507

9.  The degree of mineralization is a determinant of bone strength: a study on human calcanei.

Authors:  H Follet; G Boivin; C Rumelhart; P J Meunier
Journal:  Bone       Date:  2004-05       Impact factor: 4.398

Review 10.  What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians?

Authors:  Neil C Binkley; Peg Schmeer; Richard D Wasnich; Leon Lenchik
Journal:  J Clin Densitom       Date:  2002       Impact factor: 2.963

View more
  18 in total

1.  Low skeletal muscle mass associates with low femoral neck strength, especially in older Korean women: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV).

Authors:  B-J Kim; S H Ahn; H M Kim; S H Lee; J-M Koh
Journal:  Osteoporos Int       Date:  2014-11-13       Impact factor: 4.507

Review 2.  Bone Health During the Menopause Transition and Beyond.

Authors:  Arun S Karlamangla; Sherri-Ann M Burnett-Bowie; Carolyn J Crandall
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

3.  Pleiotropic effects of obesity on fracture risk: the Study of Women's Health Across the Nation.

Authors:  Shinya Ishii; Jane A Cauley; Gail A Greendale; Carrie Nielsen; Carrie Karvonen-Gutierrez; Kristine Ruppert; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

4.  Trajectories of femoral neck strength in relation to the final menstrual period in a multi-ethnic cohort.

Authors:  S Ishii; J A Cauley; G A Greendale; C J Crandall; M-H Huang; M E Danielson; A S Karlamangla
Journal:  Osteoporos Int       Date:  2013-02-22       Impact factor: 4.507

5.  The positive association of total protein intake with femoral neck strength (KNHANES IV).

Authors:  B-J Kim; S H Lee; C M Isales; J-M Koh; M W Hamrick
Journal:  Osteoporos Int       Date:  2018-03-06       Impact factor: 4.507

6.  Parity, lactation, bone strength, and 16-year fracture risk in adult women: findings from the Study of Women's Health Across the Nation (SWAN).

Authors:  Takahiro Mori; Shinya Ishii; Gail A Greendale; Jane A Cauley; Kristine Ruppert; Carolyn J Crandall; Arun S Karlamangla
Journal:  Bone       Date:  2014-12-18       Impact factor: 4.398

7.  Premenopausal and early postmenopausal trabecular bone score (TBS) and fracture risk: Study of Women's Health Across the Nation (SWAN).

Authors:  Gail A Greendale; MeiHua Huang; Jane A Cauley; Sioban Harlow; Joel S Finkelstein; Arun S Karlamangla
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

8.  Multisystem dysregulation and bone strength: findings from the study of midlife in the United States.

Authors:  Takahiro Mori; Arun S Karlamangla; Sharon Stein Merkin; Carolyn J Crandall; Neil Binkley; Gail A Greendale; Teresa E Seeman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

9.  C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN).

Authors:  Shinya Ishii; Jane A Cauley; Gail A Greendale; Carolyn J Crandall; Michelle E Danielson; Yasuyoshi Ouchi; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

10.  Insulin resistance and bone strength: findings from the study of midlife in the United States.

Authors:  Preethi Srikanthan; Carolyn J Crandall; Dana Miller-Martinez; Teresa E Seeman; Gail A Greendale; Neil Binkley; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.